The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
Hormonal Treatments for Major Depressive Disorder: State of the Art
Open accessAbstract
Major depressive disorder is a common psychiatric disorder associated with marked suffering, morbidity, mortality, and cost. The World Health Organization projects that by 2030, major depression will be the leading cause of disease burden worldwide. While numerous treatments for major depression exist, many patients do not respond adequately to traditional antidepressants. Thus, more effective treatments for major depression are needed, and targeting certain hormonal systems is a conceptually based approach that has shown promise in the treatment of this disorder. A number of hormones and hormone-manipulating compounds have been evaluated as monotherapies or adjunctive treatments for major depression, with therapeutic actions attributable not only to the modulation of endocrine systems in the periphery but also to the CNS effects of hormones on non-endocrine brain circuitry. The authors describe the physiology of the hypothalamic-pituitary-adrenal (HPA), hypothalamic-pituitary thyroid (HPT), and hypothalamic-pituitary-gonadal (HPG) axes and review the evidence for selected hormone-based interventions for the treatment of depression in order to provide an update on the state of this field for clinicians and researchers. The review focuses on the HPA axis–based interventions of corticotropin-releasing factor antagonists and the glucocorticoid receptor antagonist mifepristone, the HPT axis–based treatments of thyroid hormones (T3 and T4), and the HPG axis–based treatments of estrogen replacement therapy, the progesterone derivative allopregnanolone, and testosterone. While some treatments have largely failed to translate from preclinical studies, others have shown promising initial results and represent active fields of study in the search for novel effective treatments for major depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Mifepristone, which blocks both the GR and the progesterone receptors, is the most tested GR antagonist [78, 79].”
From The HPA Axis as Target for Depression (2024) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Vale, W., Spiess, J., RIVIER, C. L., & Rivier, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Kessler, R. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90026-g · Cited by 2,207
The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress
Smith, S. M., & Vale, W. W. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/ssmith · Cited by 1,948
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
Greene, R., & Dalton, K. (1953) · BMJ · doi:10.1136/bmj.1.4818.1007 · Cited by 1,819
The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09298 · Cited by 1,779
Sex differences in anxiety and depression clinical perspectives
Altemus, M., Sarvaiya, N., & Neill Epperson, C. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.05.004 · Cited by 1,413
The role of corticotropin-releasing factor in depression and anxiety disorders
Arborelius, L., Owens, M., Plotsky, P., & Nemeroff, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600001 · Cited by 1,378
Self-citationThe increasing burden of depression
Briley, M., & Lépine (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s19617 · Cited by 1,297
CRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
Stetler, C., & Miller, G. E. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31820ad12b · Cited by 1,123
Keller, J., Gomez, R., Williams, G., Lembke, A., Lazzeroni, L., Murphy, G. M., & Schatzberg, A. F. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.120 · Cited by 922
Filardo, E. J., Quinn, J. A., Frackelton, A. R., & Bland, K. I. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.1.0758 · Cited by 907
Meltzer-Brody, S., Colquhoun, H., Riesenberg, R., Epperson, C. N., Deligiannidis, K. M., Rubinow, D. R., Li, H., Sankoh, A. J., Clemson, C., Schacterle, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31551-4 · Cited by 795
Vascular effects of early versus late postmenopausal treatment with estradiol
Hodis, H. N., Mack, W. J., Henderson, V. W., Shoupe, D., Budoff, M. J., Hwang-Levine, J., Li, Y., Feng, M., Dustin, L., Kono, N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505241 · Cited by 779
Maninger, N., Wolkowitz, O. M., Reus, V. I., Epel, E. S., & Mellon, S. H. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.11.002 · Cited by 769
Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Adams, L. F., & Rubinow, D. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380401 · Cited by 765
Soares, C. N., Almeida, O., Joffe, H., & Cohen, L. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.529 · Cited by 715
Zobel, A. W., Nickel, T., Künzel, H. E., Ackl, N., Sonntag, A., Ising, M., & Holsboer, F. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00016-9 · Cited by 705
Progesterone receptors: form and function in brain
Brinton, R. D., Thompson, R. F., Foy, M. R., Baudry, M., Wang, J., Finch, C. E., Morgan, T. E., Pike, C. J., Mack, W. J., Stanczyk, F. Z., et al. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.02.001 · Cited by 675
Association of Hormonal Contraception With Depression
Skovlund, C. W., Mørch, L. S., Kessing, L. V., & Lidegaard, Ø. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.2387 · Cited by 675
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality
Manson, J. E., Aragaki, A. K., Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Chlebowski, R. T., Howard, B. V., Thomson, C. A., Margolis, K. L., et al. (2017) · JAMA · doi:10.1001/jama.2017.11217 · Cited by 663
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
Cooney, L. G., Lee, I., Sammel, M. D., & Dokras, A. (2017) · Human Reproduction · doi:10.1093/humrep/dex044 · Cited by 631
Nierenberg, A. A., D, M. F. M., Trivedi, M. H., Wisniewski, S. R., Thase, M. E., McGrath, P. J., Alpert, J. E., Warden, D., Luther, J. F., Niederehe, G., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1519 · Cited by 585
Estrogen replacement in perimenopause-related depression: A preliminary report
Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Tobin, M., Roca, C. A., Murphy, J. H., & Rubinow, D. R. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106004 · Cited by 572
Very Early Administration of Progesterone for Acute Traumatic Brain Injury
Wright, D. W., Yeatts, S. D., Silbergleit, R., Palesch, Y. Y., Hertzberg, V. S., Frankel, M., Goldstein, F. C., Caveney, A. F., Howlett-Smith, H., Bengelink, E. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404304 · Cited by 567
The Link between Thyroid Function and Depression
Hage, M. P., & Azar, S. T. (2012) · Journal of Thyroid Research · doi:10.1155/2012/590648 · Cited by 549
Gleason, C. E., Dowling, N. M., Wharton, W., Manson, J. E., Miller, V. M., Atwood, C., Brinton, E. A., Cedars, M. I., Løbo, R. A., Merriam, G. R., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001833 · Cited by 512
A Clinical Trial of Progesterone for Severe Traumatic Brain Injury
Skolnick, B. E., Maas, A. I., Narayan, R. K., van der Hoop, R. G., MacAllister, T., Ward, J. D., Nelson, N. R., & Stocchetti, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1411090 · Cited by 505
Triiodothyronine Augmentation in the Treatment of Refractory Depression
Aronson, R. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830090090013 · Cited by 488
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.
Kanes, S., Colquhoun, H., Gunduz-Bruce, H., Raines, S., Arnold, R., Schacterle, A., Doherty, J., Epperson, C. N., Deligiannidis, K. M., Riesenberg, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31264-3 · Cited by 479
The Thyroid‐Brain Interaction in Thyroid Disorders and Mood Disorders
Bauer, M., Goetz, T., Glenn, T., & Whybrow, P. C. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01774.x · Cited by 457
A Reappraisal of Testosterone’s Binding in Circulation: Physiological and Clinical Implications
Goldman, A. L., Bhasin, S., Wu, F. C. W., Krishna, M., Matsumoto, A. M., & Jasuja, R. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00025 · Cited by 414
Double-blind treatment of major depression with dehydroepiandrosterone.
Wolkowitz, O. M., Reus, V. I., Keebler, A., Nelson, N., Friedland, M., Brizendine, L., & Roberts, E. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.646 · Cited by 411
Merali, Z., Du, L., Hrdina, P., Palkovits, M., Faludi, G., Poulter, M. O., & Anisman, H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4734-03.2004 · Cited by 400
Testosterone and Depression: Systematic Review and Meta-Analysis
Zarrouf, F. A., Artz, S., Griffith, J., Sirbu, C., & Kommor, M. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000358315.88931.fc · Cited by 383
Premenstrual Dysphoric Disorder: Epidemiology and Treatment
Hantsoo, L. V., & Epperson, C. N. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0628-3 · Cited by 376
Hill, M. N., McLaughlin, R. J., Pan, B., Fitzgerald, M. L., Roberts, C. J., Lee, T. T. Y., Karatsoreos, I. N., Mackie, K., Viau, V., Pickel, V. M., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0496-11.2011 · Cited by 375
Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action
Hammond, G. L. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0070 · Cited by 356
Efficacy of a New Low-Dose Oral Contraceptive With Drospirenone in Premenstrual Dysphoric Disorder
Yonkers, K. A., Brown, C., Pearlstein, T. B., Foegh, M. L., Sampson-Landers, C., & Rapkin, A. J. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000175834.77215.2e · Cited by 349
Ising, M., Horstmann, S., Kloiber, S., Lucae, S., Binder, E. B., Kern, N., Künzel, H. E., Pfennig, A., Uhr, M., & Holsboer, F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.039 · Cited by 341
Pope, H. G., Cohane, G. H., Kanayama, G., Siegel, A. J., & Hudson, J. I. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.105 · Cited by 341
CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia
Bánki, C. M., Bissette, G., Arató, M., O'Connor, L., & Nemeroff, C. B. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.7.873 · Cited by 336
Self-citationFast Feedback Inhibition of the HPA Axis by Glucocorticoids Is Mediated by Endocannabinoid Signaling
Evanson, N. K., Tasker, J. G., Hill, M. N., Hillard, C. J., & Herman, J. P. (2010) · Endocrinology · doi:10.1210/en.2010-0285 · Cited by 324
Estrogen Replacement and Response to Fluoxetine in a Multicenter Geriatric Depression Trial
Schneider, L. S. S., Small, G. W., Hamilton, S. H., Bystritsky, A., Nemeroff, C. B., & Meyers, B. S. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199700520-00002 · Cited by 297
Self-citation60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-pituitary–gonadal axis
Plant, T. M. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0113 · Cited by 289
Pearlstein, T. B., Bachmann, G. A., Zacur, H. A., & Yonkers, K. A. (2005) · Contraception · doi:10.1016/j.contraception.2005.08.021 · Cited by 278
Mechanisms of rapid glucocorticoid feedback inhibition of the hypothalamic–pituitary–adrenal axis
Tasker, J. G., & Herman, J. P. (2011) · Stress · doi:10.3109/10253890.2011.586446 · Cited by 277
Frye, C. A., & Walf, A. A. (2002) · Hormones and Behavior · doi:10.1006/hbeh.2002.1763 · Cited by 268
Bäckström, T. C., Sanders, D., Leask, R., Davidson, D., Warner, P., & Bancroft, J. (1983) · Psychosomatic Medicine · doi:10.1097/00006842-198312000-00004 · Cited by 266
Gordon, J. L., Rubinow, D. R., Eisenlohr-Moul, T. A., Xia, K., Schmidt, P. J., & Girdler, S. S. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3998 · Cited by 262
Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression
Schmidt, P. J., Daly, R. C., Bloch, M., SMITH, M. J., Danaceau, M. A., Clair, L. S. S., Murphy, J. H., Haq, N., & Rubinow, D. R. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.154 · Cited by 256
Rapid Cycling Bipolar Affective Disorder
Bauer, M. S. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810170035006 · Cited by 254
Binneman, B., Feltner, D., Kolluri, S., Shi, Y., Qiu, R., & Stiger, T. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071199 · Cited by 254
Nemeroff, C. B., Bissette, G., Akil, H., & Fink, M. (1991) · The British Journal of Psychiatry · doi:10.1192/bjp.158.1.59 · Cited by 251
Self-citationAltshuler, L. L., Bauer, M., Frye, M. A., Gitlin, M. J., Mintz, J., Szuba, M. P., Leight, K. L., & Whybrow, P. C. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1617 · Cited by 250
Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial
Morrison, M. F., Kallan, M. J., Have, T. T., Katz, I. R., Tweedy, K., & Battistini, M. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.011 · Cited by 245
Increased Incidence of Diagnosed Depressive Illness in HypogonadalOlder Men
Shores, M. M., Sloan, K. L., Matsumoto, A. M., Moceri, V. M., Felker, B., & Kivlahan, D. R. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.2.162 · Cited by 243
Reversal of neurosteroid effects at α4β2δ GABAA receptors triggers anxiety at puberty
Shen, H., Gong, Q. H., Aoki, C. J., Yuan, M., Ruderman, Y., Dattilo, M., Williams, K. L., & Smith, S. S. (2007) · Nature Neuroscience · doi:10.1038/nn1868 · Cited by 243
Scammell, J. G., Denny, W. B., Valentine, D. L., & Smith, D. F. (2001) · General and Comparative Endocrinology · doi:10.1006/gcen.2001.7696 · Cited by 238
Neurosteroid binding sites on GABAA receptors
Hosie, A. M., Wilkins, M. E., & Smart, T. G. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.011 · Cited by 224
Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals
Vendruscolo, L. F., Estey, D., Goodell, V., Macshane, L. G., Logrip, M. L., Schlosburg, J. E., McGinn, M. A., Zamora-Martinez, E. R., Belanoff, J. K., Hunt, H. J., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79828 · Cited by 218
Cortisol Circadian Rhythm Alterations in Psychotic Major Depression
Keller, J., Flores, B., Gomez, R. G., Solvason, H. B., Kenna, H., Williams, G. H., & Schatzberg, A. F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.014 · Cited by 217
Rabkin, J. G., Wagner, G. J., & Rabkin, R. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.2.141 · Cited by 213
Shughrue, P. J., Bushnell, C. D., & Dorsa, D. M. (1992) · Endocrinology · doi:10.1210/endo.131.1.1612018 · Cited by 211
Major Depression in Late Life Is Associated with Both Hypo- and Hypercortisolemia
Bremmer, M. A., Deeg, D. J. H., Beekman, A. T. F., Penninx, B. W. J. H., Lips, P. T. A. M., & Hoogendijk, W. J. G. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.033 · Cited by 207
Neurosteroids, stress and depression: Potential therapeutic opportunities
Zorumski, C. F., Paul, S. M., Izumi, Y., Covey, D. F., & Mennerick, S. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.005 · Cited by 204
Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression
Flores, B. H., Kenna, H., Keller, J., Solvason, H. B., & Schatzberg, A. F. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300884 · Cited by 203
Association of Hormonal Contraception With Suicide Attempts and Suicides
Skovlund, C. W., Mørch, L. S., Kessing, L. V., Lange, T., & Lidegaard, Ø. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17060616 · Cited by 197
Thyroid Hormones, T3 and T4, in the Brain
Schroeder, A. C., & Privalsky, M. L. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00040 · Cited by 191
On the effects of testosterone on brain behavioral functions
Celec, P., Ostatníková, D., & Hodosy, J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00012 · Cited by 190
Zhou, X., Ravindran, A. V., Qin, B., Del Giovane, C., Li, Q., Bauer, M., Liu, Y., Fang, Y., da Silva, T., Zhang, Y., et al. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14r09204 · Cited by 189
The Role of the Forebrain Glucocorticoid Receptor in Acute and Chronic Stress
Furay, A. R., Packard, A. E. B., & Herman, J. P. (2008) · Endocrinology · doi:10.1210/en.2008-0642 · Cited by 189
Metyrapone as Additive Treatment in Major Depression: A Double-blind and Placebo-Controlled Trial
Jahn, H., Schick, M., Kiefer, F., Kellner, M., Yassouridis, A., & Wiedemann, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.12.1235 · Cited by 184
Rachman, I. M., Unnerstall, J. R., Pfaff, D. W., & Cohen, R. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13941 · Cited by 182
Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men
Walther, A., Breidenstein, J., & Miller, R. E. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.2734 · Cited by 182
Estrogen Replacement and Response to Fluoxetine in a Multicenter Geriatric Depression Trial
Schneider, L. S., Small, G. W., Hamilton, S. H., et al. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199721520-00002 · Cited by 179
Stress and Depression: a Crucial Role of the Mineralocorticoid Receptor
de Kloet, E. R., Otte, C., Kumsta, R., Kok, L., Hillegers, M. H. J., Hasselmann, H., Kliegel, D., & Joëls, M. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12379 · Cited by 177
Coric, V., Feldman, H., Oren, D. A., Shekhar, A., Pultz, J. A., Dockens, R. C., Wu, X., Gentile, K. A., Huang, S.-P., Emison, E., et al. (2010) · Depression and Anxiety · doi:10.1002/da.20695 · Cited by 172
Progress in corticotropin-releasing factor-1 antagonist development
Zorrilla, E. P., & Koob, G. F. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.02.011 · Cited by 167
Regulation of cortisol bioavailability—effects on hormone measurement and action
Perogamvros, I., Ray, D. W., & Trainer, P. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.134 · Cited by 167
Lundin, C., Gemzell‐Danielsson, K., Bixo, M., Moby, L., Bengtsdotter, H., Jawad, I., Marions, L., Brynhildsen, J., Malmborg, A., Lindh, I., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.11.033 · Cited by 167
Antiglucocorticoid treatment of depression: double-blind ketoconazole
Wolkowitz, O. M., Reus, V. I., Chan, T., Manfredi, F., Raum, W. J., Johnson, R., & Canick, J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00267-4 · Cited by 165
DeBattista, C., Belanoff, J., Glass, S., Khan, A., Horne, R. L., Blasey, C., Carpenter, L. L., & Alva, G. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.034 · Cited by 162
Self-citationDokras, A., Sarwer, D. B., Allison, K. C., Milman, L., Kris-Etherton, P. M., Kunselman, A. R., Stetter, C. M., Williams, N. I., Gnatuk, C. L., Estes, S. J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1896 · Cited by 161
A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants
Joffe, R. T., & Singer, W. (1990) · Psychiatry Research · doi:10.1016/0165-1781(90)90029-5 · Cited by 156
Martinez, P. E., Rubinow, D. R., Nieman, L. K., Koziol, D. E., Morrow, A. L., Schiller, C. E., Cintrón-López, D., Thompson, K., Khine, K., & Schmidt, P. J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.246 · Cited by 155
Effects of Hypogonadism and Testosterone Administration on Depression Indices in HIV-Infected Men
Grinspoon, S. K., Corcoran, C. P., Stanley, T. L., Baaj, A., Basgoz, N. O., & Klibanski, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6224 · Cited by 155
Glucocorticoid Signaling: An Update from a Genomic Perspective
Sacta, M. A., Chinenov, Y. V., & Rogatsky, I. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105323 · Cited by 155
Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis
Elliott, J., Kelly, S., Millar, A. C., Peterson, J., Chen, L., Johnston, A., Kotb, A., Skidmore, B., Bai, Z., Mamdani, M., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015284 · Cited by 154
Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression
Kanes, S. J., Colquhoun, H., Doherty, J., Raines, S., Hoffmann, E., Rubinow, D. R., & Meltzer-Brody, S. (2017) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2576 · Cited by 151
Watson, S., Gallagher, P., Porter, R. J., Smith, M. S., Herron, L. J., Bulmer, S., Young, A. H., & Ferrier, I. N. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.029 · Cited by 145
Liothyronine for Depression: A Review and Guidance for Safety Monitoring.
Jaffer, K. Y., Chang, T., Vanle, B., Dang, J., Steiner, A. J., Loera, N., Abdelmesseh, M., Danovitch, I., & IsHak, W. W. (2017) · PubMed Central · Cited by 142
Combined hormonal contraception and its effects on mood: a critical review
Schaffir, J., Worly, B. L., & Gur, T. (2016) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2016.1217327 · Cited by 140
Thyroid Functions and Bipolar Affective Disorder
Chakrabarti, S. (2011) · Journal of Thyroid Research · doi:10.4061/2011/306367 · Cited by 132
Otte, C., Hinkelmann, K., Moritz, S., Yassouridis, A., Jahn, H., Wiedemann, K., & Kellner, M. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.10.006 · Cited by 129
Thyroid dysfunction in refractory depression: implications for pathophysiology and treatment.
Howland, R. H. (1993) · PubMed · Cited by 128
Treatment of Major Depression with metyrapone and hydrocortisone
O’Dwyer, A.-M., Lightman, S. L., Marks, M. N., & Checkley, S. A. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)00082-k · Cited by 127
Shores, M. M., Kivlahan, D. R., Sadak, T. I., Li, E. J., & Matsumoto, A. M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04478 · Cited by 123
Jaferi, A., & Bhatnagar, S. (2006) · Endocrinology · doi:10.1210/en.2005-1393 · Cited by 122
Joffe, H., Petrillo, L. F., Koukopoulos, A. E., Viguera, A. C., Hirschberg, A., Nonacs, R. M., Somley, B., Cahill, E. P., White, D. P., Hall, J. E., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2503 · Cited by 119
Non-genomic mechanisms of progesterone action in the brain
Singh, M., Su, C., & Ng, S. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00159 · Cited by 117
Perraudin, V., Delarue, C., Lefèbvre, H., Contesse, V., Kuhn, J., & Vaudry, H. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.7684742 · Cited by 115
Allopregnanolone as a mediator of affective switching in reproductive mood disorders
Schiller, C. E., Schmidt, P. J., & Rubinow, D. R. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3599-x · Cited by 113
Russell, G. M., Henley, D. E., Leendertz, J., Douthwaite, J. A., Wood, S. A., Stevens, A., Woltersdorf, W. W., Peeters, B. W. M. M., Ruigt, G. S. F., White, A., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5332-09.2010 · Cited by 111
Calculated bioavailable testosterone levels and depression in middle-aged men
McIntyre, R. S., Mancini, D., Eisfeld, B. S., Soczynska, J. K., Grupp, L. A., Konarski, J. Z., & Kennedy, S. H. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.06.005 · Cited by 110
The relationship between progestin hormonal contraception and depression: a systematic review
Worly, B. L., Gur, T., & Schaffir, J. (2018) · Contraception · doi:10.1016/j.contraception.2018.01.010 · Cited by 108
Amanatkar, H. R., Chibnall, J. T., Seo, B.-W., Manepalli, J. N., & Grossberg, G. T. (2014) · Annals of Clinical Psychiatry · doi:10.1177/104012371402600103 · Cited by 106
Enhancement of Imipramine by Thyroid Stimulating Hormone: Clinical and Theoretical Implications
Prange, A. J., Wilson, I. C., KNOX, A., McClane, T. K., & Lipton, M. A. (1970) · American Journal of Psychiatry · doi:10.1176/ajp.127.2.191 · Cited by 104
Rabkin, J., McElhiney, M., Rabkin, R., McGrath, P., & Ferrando, S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.59 · Cited by 101
Freeman, E. W., Halbreich, U. M., Grubb, G. S., Rapkin, A. J., Skouby, S. O., Smith, L. M., Mirkin, S., & Constantine, G. D. (2011) · Contraception · doi:10.1016/j.contraception.2011.09.010 · Cited by 98
Testosterone Versus Fluoxetine for Depression and Fatigue in HIV/AIDS
Rabkin, J. G., Wagner, G. J., McElhiney, M. C., Rabkin, R., & Lin, S. H. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000132442.35478.3c · Cited by 96
A Randomized, Double-Blind, Placebo-Controlled Trial of Pregnenolone for Bipolar Depression
Brown, E. S., Park, J., Marx, C. E., Hynan, L. S., Gardner, C., Davila, D., Nakamura, A., Sunderajan, P., Lo, A., & Holmes, T. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.138 · Cited by 96
Dunlop, B. W., Binder, E. B., Iosifescu, D., Mathew, S. J., Neylan, T. C., Pape, J. C., Carrillo-Roa, T., Green, C., Kinkead, B., Grigoriadis, D., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.06.024 · Cited by 96
Self-citationRotondo, F., Butz, H., Syro, L. V., Yousef, G. M., Di Ieva, A., Restrepo, L. M., Quintanar-Stephano, A., Berczi, I., & Kovacs, K. (2016) · Pituitary · doi:10.1007/s11102-015-0703-0 · Cited by 93
Jutkiewicz, E. M., Wood, S. K., Houshyar, H., Hsin, L., Rice, K. C., & Woods, J. H. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2164-z · Cited by 92
Pope, H. G., Amiaz, R., Brennan, B. P., Orr, G., Weiser, M., Kelly, J. F., Kanayama, G., Siegel, A., Hudson, J. I., & Seidman, S. N. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181d207ca · Cited by 90
Ismaili, E., Walsh, S., O'Brien, P., Bäckström, T., Brown, C. S., Dennerstein, L., Eriksson, E., Freeman, E., Ismail, K., Panay, N., et al. (2016) · Archives of Women's Mental Health · doi:10.1007/s00737-016-0631-7 · Cited by 90
Bixo, M., Johansson, M., Timby, E., Michalski, L., & Bäckström, T. C. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12553 · Cited by 86
Nicolaides, N. C., Charmandari, E., Chrousos, G. P., & Kino, T. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-71 · Cited by 83
Peripheral thyroid dysfunction in depression
Fountoulakis, K. Ν., Kantartzis, S., Siamouli, M., Panagiotidis, P., Kaprinis, S. G., Iacovides, A., & KAPRINIS, G. S. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970500474739 · Cited by 80
Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice
Nielsen, D. M., Carey, G. J., & Gold, L. H. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.091 · Cited by 80
Orengo, C. A., Fullerton, L., & Kunik, M. E. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988704271767 · Cited by 79
EFFICACY OF ESTRADIOL IN PERIMENOPAUSAL DEPRESSION: SO MUCH PROMISE AND SO FEW ANSWERS
Rubinow, D., Johnson, S., Schmidt, P. J., Girdler, S., & Gaynes, B. (2015) · Depression and Anxiety · doi:10.1002/da.22391 · Cited by 79
Rasgon, N., Dunkin, J. J., Fairbanks, L. A., Altshuler, L. L., Troung, C., Elman, S., Wroolie, T., Brunhuber, M. V., & Rapkin, A. J. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.03.009 · Cited by 79
Cohen, B. M., Sommer, B. R., & Vuckovic, A. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17080949 · Cited by 79
Block, T. S., Kushner, H., Kalin, N., Nelson, C., Belanoff, J., & Schatzberg, A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.008 · Cited by 78
Self-citationIshitobi, Y., Nakayama, S., Yamaguchi, K., Kanehisa, M., Higuma, H., Maruyama, Y., Ninomiya, T., Okamoto, S., Tanaka, Y., Tsuru, J., et al. (2012) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32046 · Cited by 77
The Effect of Testosterone Levels on Mood in Men: A Review
Johnson, J. M., Nachtigall, L. B., & Stern, T. A. (2013) · Psychosomatics · doi:10.1016/j.psym.2013.06.018 · Cited by 76
Walshaw, P. D., Gyulai, L., Bauer, M., Bauer, M. S., Calimlim, B., Sugar, C. A., & Whybrow, P. C. (2018) · Bipolar Disorders · doi:10.1111/bdi.12657 · Cited by 74
Efficacy and Safety of Mifepristone for the Treatment of Psychotic Depression
Blasey, C. M., Block, T. S., Belanoff, J. K., & Roe, R. L. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182239191 · Cited by 73
Seidman, S. N., Miyazaki, M., & Roose, S. P. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000185424.23515.e5 · Cited by 70
Raven, P., O’Dwyer, A.-M., Taylor, N., & Checkley, S. A. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00057-7 · Cited by 68
Thyroid Hormones and Depression: The Health In Men Study
Almeida, O. P., Alfonso, H., Flicker, L., Hankey, G., Chubb, S. A. P., & Yeap, B. B. (2011) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31820dcad5 · Cited by 68
Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia
Marx, C. E., Lee, J., Subramaniam, M., Rapisarda, A., Bautista, D., Chan, E. S., Kilts, J. D., Buchanan, R. W., Eu, P. W., Verma, S. K., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3673-4 · Cited by 67
A randomized controlled trial of ganaxolone in posttraumatic stress disorder
Rasmusson, A. M., Marx, C. E., Jain, S., Farfel, G. M., Tsai, J., Sun, X., Geracioti, T. D., Hamner, M. B., Lohr, J. B., Rosse, R. B., et al. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4649-y · Cited by 66
Blum, M. R., Wijsman, L. W., Virgini, V. S., Bauer, D. C., den Elzen, W. P. J., Jukema, J. W., Buckley, B. M., de Craen, A. J. M., Kearney, P. M., Stott, D. J., et al. (2015) · Neuroendocrinology · doi:10.1159/000437387 · Cited by 64
Clinical and Subclinical Hypothyroidism in Patients with Chronic and Treatment-Resistant Depression
Hickie, I. B., Bennett, B. K., Mitchell, P. B., Wilhelm, K. A., & Orlay, W. (1996) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679609076101 · Cited by 64
Evans, D. L., & Nemeroff, C. B. (1987) · Journal of Psychiatric Research · doi:10.1016/0022-3956(87)90018-5 · Cited by 64
Self-citationEffects of Testosterone Replacement in Middle-Aged Men With Dysthymia
Seidman, S. N., Orr, G., Raviv, G., Levi, R., Roose, S. P., Kravitz, E., Amiaz, R., & Weiser, M. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a39137 · Cited by 63
Sperling, M. R., Klein, P., & Tsai, J. (2017) · Epilepsia · doi:10.1111/epi.13705 · Cited by 63
Blasey, C. M., DeBattista, C., Roe, R., Block, T., & Belanoff, J. K. (2009) · Contemporary Clinical Trials · doi:10.1016/j.cct.2009.03.001 · Cited by 61
Limited Efficacy of Ketoconazole in Treatment-Refractory Major Depression
Malison, R. T., Anand, A., Pelton, G. H., Kirwin, P. D., Carpenter, L. L., McDougle, C. J., Heninger, G. R., & Price, L. H. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199910000-00011 · Cited by 61
Self-citationWestley, C. J., AMDUR, R. L., & Irwig, M. S. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12937 · Cited by 54
Plasma Testosterone and the Course of Major Depressive Disorder in Older Men and Women
Giltay, E. J., van der Mast, R. C., Lauwen, E., Heijboer, A. C., de Waal, M. W. M., & Comijs, H. C. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.12.014 · Cited by 54
Buckley, T. M., Mullen, B. C., & Schatzberg, A. F. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.05.016 · Cited by 51
Schatzberg, A. F. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.916414 · Cited by 51
Testosterone Therapy: Review of Clinical Applications.
Petering, R. C., & Brooks, N. A. (2017) · PubMed · Cited by 51
Prevalence of depression in patients affected by subclinical hypothyroidism.
Demartini, B., Masu, A., Scarone, S., Pontiroli, A. E., & Gambini, O. (2010) · PubMed · Cited by 50
Hormone treatment of depression
Joffe, R. T. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/rjoffe · Cited by 50
Supraphysiologic Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression
Stamm, T. J., Lewitzka, U., Sauer, C., Pilhatsch, M., Smolka, M. N., Köberle, U., Adli, M., Ricken, R., Scherk, H., Frye, M. A., et al. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08305 · Cited by 47
McAllister-Williams, R. H., Anderson, I. M., Finkelmeyer, A., Gallagher, P., Grunze, H. C. R., Haddad, P. M., Hughes, T., Lloyd, A. J., Mamasoula, C., McColl, E., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00436-8 · Cited by 47
Block, T., Petrides, G., Kushner, H., Kalin, N., Belanoff, J., & Schatzberg, A. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000744 · Cited by 47
Self-citationPapakostas, G. I., Cooper‐Kazaz, R., Appelhof, B. C., Posternak, M. A., Johnson, D. P., Klibanski, A., Lerer, B., & D, M. F. M. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328314dfaf · Cited by 45
Postmortem and Cerebrospinal Fluid Studies of Corticotropin‐releasing Factor in Humansa
HARTLINE, K. M., Owens, M. J., & Nemeroff, C. B. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb15114.x · Cited by 44
Self-citationThe use of hormonal contraceptive agents and mood disorders in women
Svendal, G., Berk, M., Pasco, J. A., Jacka, F. N., Lund, A., & Williams, L. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.030 · Cited by 43
Murphy, B. E. P., GHADIRIAN, A. M., & Dhar, V. (1998) · The Canadian Journal of Psychiatry · doi:10.1177/070674379804300307 · Cited by 42
Seidman, S. N., & Roose, S. P. (2006) · Journal of Sex & Marital Therapy · doi:10.1080/00926230600575355 · Cited by 40
Rudolph, I., Palombo‐Kinne, E., Kirsch, B., Mellinger, U., Breitbarth, H., & Gräser, T. (2004) · Climacteric · doi:10.1080/13697130400001802 · Cited by 39
T 3 Augmentation in Major Depressive Disorder: Safety Considerations
Rosenthal, L. J., Goldner, W. S., & O’Reardon, J. P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10030402 · Cited by 38
Johnson, D. A., Grant, E. J., Ingram, C. D., & Gartside, S. E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.003 · Cited by 38
Talaeı, A., Pourgholami, M., Khatibi-Moghadam, H., Farıdhosseını, F., Farhoudi, F., Askari-Noghani, A., & Sadeghi, R. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000492 · Cited by 38
Menke, A., Arloth, J., Best, J., Namendorf, C., Gerlach, T., Czamara, D., Lucae, S., Dunlop, B. W., Crowe, T. M., Garlow, S. J., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.04.003 · Cited by 35
Self-citationGABAA Receptor-Modulating Steroids in Relation to Women’s Behavioral Health
Bäckström, T. C., Bixo, M., & Strömberg, J. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0627-4 · Cited by 34
Jung, H. J., & Shin, H. S. (2016) · The World Journal of Men s Health · doi:10.5534/wjmh.2016.34.3.194 · Cited by 34
Dias, R. D. S., Kerr-Corrêa, F., Moreno, R. A., Trinca, L. A., Pontes, A., Halbe, H. W., Gianfaldoni, A., & Dalben, I. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000198491.34371.9c · Cited by 33
A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia.
Khodaie-Ardakani, M.-R., Khosravi, M., Zarinfard, R., Nejati, S., Mohsenian, A., Tabrizi, M. H., & Akhondzadeh, S. (2015) · PubMed · Cited by 33
Lithium and Triiodothyronine Augmentation of Antidepressants
Joffe, R. T., Sokolov, S. T. H., & LEVITT, A. J. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605101209 · Cited by 32
The ACTH stimulation test before and after clinical recovery from depression
Amsterdam, J. D., Maislin, G., Droba, M., & Winokur, A. (1987) · Psychiatry Research · doi:10.1016/0165-1781(87)90094-1 · Cited by 31
Rogóż, Z., Skuza, G., Wójcikowski, J., Daniel, W. A., Wróbel, A., Dudek, D., & Zięba, A. (2004) · PubMed · Cited by 27
Smith, J. B., Rosen, J. H., & Colbert, A. (2017) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.08.007 · Cited by 26
Risk-reducing medication for primary breast cancer: a network meta-analysis
D, S. M. M., Goodwin, A., & Pasquali, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012191 · Cited by 20
Development of New Psychopharmacological Agents for Depression and Anxiety
Schatzberg, A. F. (2015) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.05.009 · Cited by 19
Cognitive functioning and cortisol suppression in recurrent major depression
Hansson, P. B., Murison, R. C. C., Lund, A., & Hammar, Å. (2013) · PsyCh Journal · doi:10.1002/pchj.29 · Cited by 14
Should Hormone Therapy Be Used to Prevent Depressive Symptoms During the Menopause Transition?
Joffe, H., & Hickey, M. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3945 · Cited by 13
Zibara, K., Zein, N. E., Sabra, M., Hneino, M., Harati, H., Mohamed, W. M. Y., Kobeissy, F. H., & Kassem, N. A. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00214 · Cited by 8
Research works printed but not linked: 11
- Lépine JP, 2011, Neuropsychiatr Dis Treat, 7, 3
- Perraudin V, 1993, J Clin Endocrinol Metab, 76, 1522
- Rogóz Z, 2004, Pol J Pharmacol, 56, 849
- Howland RH, 1993, J Clin Psychiatry, 54, 47
- Demartini B, 2010, Panminerva Med, 52, 277
- Touma KTB, 2017, Innov Clin Neurosci, 14, 24
- Mocellin S, 2019, Cochrane Database Syst Rev, 4, CD012191
- Khodaie-Ardakani MR, 2015, Acta Med Iran, 53, 337
- Amanatkar HR, 2014, Ann Clin Psychiatry, 26, 19
- Grinspoon S, 2000, J Clin Endocrinol Metab, 85, 60
- Petering RC, 2017, Am Fam Physician, 96, 441
Cited by
Sorted by citations
Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00454-1 · Cited by 910
Candidate biomarkers in psychiatric disorders: state of the field
Abi‐Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., et al. (2023) · World Psychiatry · doi:10.1002/wps.21078 · Cited by 421
The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders
Hwang, W. J., Lee, T. Y., Kim, N. S., & Kwon, J. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010373 · Cited by 222
The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders
Sanacora, G., Yan, Z., & Popoli, M. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00540-x · Cited by 197
Li, D., Liu, R., Wang, M., Peng, R., Fu, S., Fu, A., Le, J., Yao, Q., Yuan, T., Chi, H., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.01.001 · Cited by 155
Metadata
- Authors
- Dwyer, J. B., Aftab, A., Radhakrishnan, R., Widge, A., Rodriguez, C. I., Carpenter, L. L., Nemeroff, C. B., McDonald, W. M., Kalin, N. H., & APA Council of Research Task Force on Novel Biomarkers and Treatments
- Affiliations
- University of Minnesota (US)
- Child Study Center and Department of Radiology and Biomedical Imaging, Yale University, New Haven, Conn. (Dwyer); Department of Psychiatry, Case Western Reserve University, Cleveland, and Northcoast Behavioral Healthcare Hospital, Northfield, Ohio (Aftab); Yale School of Medicine, New Haven, Conn. (Radhakrishnan); Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis (Widge); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, Calif., and VA...
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2020-08-01
- Volume
- 177
- Issue
- 8
- Pages
- 686-705
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC7841732
- OpenAlex
- W3031744338
- Cited by
- 252
- References
- 184
- Citations by year
- 2026: 25 · 2025: 49 · 2024: 59 · 2023: 53 · 2022: 49 · 2021: 13 · 2020: 4
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR001863)
- National Institute of Mental Health (R01MH119384, R21MH111501, T32MH018268)
- National Institute of Neurological Disorders and Stroke (UH3NS100548)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- major depressive disorder, hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-thyroid axis, hypothalamic-pituitary-gonadal axis, mifepristone, glucocorticoid receptor, thyroid hormones, estrogen replacement therapy, allopregnanolone, testosterone, treatment-resistant depression, endocrine modulation
- MeSH terms
- Major Depressive Disorder, Endocrine Glands, Hormones, Humans, Neurosecretory Systems, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
